Evidence map›Paper›PMID 42298663›Full record

ReviewBMC veterinary research2026

Livestock immunomodulators as alternatives to antimicrobials - a roadmap for the fight against drug resistance.

Daniel S Ackerman, Alex Morrow, Adrian L Smith, Gary Entrican

Abstract readReview
In one paragraph

Review in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel S AckermanInsight Editing London, London, UK.
Alex MorrowCABI, Nosworthy Way, Wallingford, Oxfordshire, OX10 8DE, UK.
Adrian L SmithDepartment of Biology, Medawar Building, University of Oxford, South Parks Road, Oxford, OX1 3SY, UK.
Gary EntricanThe Roslin Institute at University of Edinburgh, Easter Bush Campus, Edinburgh, Midlothian, EH25 9RG, UK. gary.entrican@roslin.ed.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council 10055666British Council ISPF Programme 1154EMIDA/Defra OD0221European Union SIRCAH 2 101082377John Fell Fund, University of Oxford AT4072
6 · The paper itself

Abstract

Antimicrobials are currently an indispensable pillar of the animal production industry, relied upon to treat diseases that could otherwise severely impact animal welfare and productivity. However, overuse of antimicrobials is driving the selection of drug-resistant microbes. Coupled with the rising demands placed on animal production systems by the growing human population, we now face an increasingly urgent need for new strategies to address animal diseases and their impacts on productivity, efficiency, and welfare. The identification and development of alternatives to antimicrobials is therefore a critical and fast-growing field of research. The STAR IDAZ International Research Consortium recently conducted workshops that recruited international experts to develop research roadmaps aiming to stratify, organise, and clarify the ongoing research and outstanding questions that currently define the field of alternatives to antimicrobials. This review will explore the roadmap that deals with immunomodulators, a broad class of technologies that aim to beneficially alter host immunity in ways that promote animal health and growth, mitigate disease, and improve welfare at the human-animal interface. We will discuss the STAR IDAZ immunomodulators roadmap in detail, addressing the foundational biology underlying immunomodulation; the fields of research that link livestock immunity and metabolism with response to infections; and the immunomodulator technologies that are currently under development.

Indexed as

Immunologic FactorsImmunomodulating AgentsLivestockAnimalsAnti-Infective AgentsDrug Resistance, MicrobialAnti-Infective AgentsImmunologic FactorsImmunomodulating AgentsAdaptive immunityAlternatives to antimicrobialsAntimicrobial peptidesAntimicrobial resistanceHost defence peptidesHost-pathogen interactionsImmunomodulatorsInnate immunityPhytochemicalsTLR agonists

Identifiers

PMID42298663
PMCPMC13508437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.